Guy S. Reeder, M.D., Raymond J. Gibbons, M.D. Mayo Clinic Proceedings

Slides:

Advertisements

Similar presentations

Use of Doppler Techniques (Continuous-Wave, Pulsed-Wave, and Color Flow Imaging) in the Noninvasive Hemodynamic Assessment of Congenital Heart Disease.

Advertisements

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

NICHOLAS J. TALLEY, M.B., Ph.D., SIDNEY F. PHILLIPS, M.D.

Robert A. Guyton, MD The Annals of Thoracic Surgery

L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis James J. DiNicolantonio, PharmD, Carl J. Lavie,

Managing Cancer Pain: Basic Principles and Invasive Treatments

Contemporary Diagnosis and Management of Unstable Angina

Use of the Coronary Artery Calcium Score in Discussion of Initiation of Statin Therapy in Primary Prevention Erin D. Michos, MD, MHS, Michael J. Blaha,

Kayser-Fleischer Rings in a Patient With Basal Cell Carcinoma: Fortuitous Diagnosis of Presymptomatic Wilson's Disease DAVID G. BRODLAND, M.D. Mayo.

J. Eric Ahlskog, PhD, MD Mayo Clinic Proceedings

Noninvasive Ventilation

Evaluation of Proteinuria

De Novo Systemic Vasculitis in a Renal Transplant Recipient

Diagnostic Options for Assessment of Postmenopausal Bleeding

Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy: Case Discussion and Review of the Literature Paul Y. Kwo, M.D., William J. Tremaine, M.D. Mayo.

Treatment of Alcohol Withdrawal in Hospitalized Patients

Robert A. Guyton, MD The Annals of Thoracic Surgery

Obsessive Compulsive Disorder: A Clinical Update

Commonly Asked Questions About Thyroid Function

Sudden Cardiac Death From the Perspective of Coronary Artery Disease

Peripheral Arterial Disease: Diagnosis and Management

George Dailey, MD Mayo Clinic Proceedings

JOANNE H. VAN WOERT, M.D. Mayo Clinic Proceedings

Gestational Trophoblastic Disease

Palliative Care and Hospice Programs

Topical Analgesics in the Management of Acute and Chronic Pain

George E. Kikano, MD, Marie T. Brown, MD Mayo Clinic Proceedings

Management of Graves' Ophthalmopathy With Optic Nerve Involvement

James H. O'Keefe, M.D., Carl J. Lavie, M.D., Ben D. McCallister, M.D.

Coronary Angioplasty in Acute Myocardial Infarction: Primary, Immediate Adjunctive, Rescue, or Deferred Adjunctive Approach? ROBERT D. SIMARI, M.D.,

To B or Not to B: Is Non–High-Density Lipoprotein Cholesterol an Adequate Surrogate for Apolipoprotein B? Carl J. Lavie, MD, Richard V. Milani, MD, James.

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Pancreatic Ductal Adenocarcinoma

Risk Stratification and Interventional Cardiology: Robert L

Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease Robert.

R. Scott Wright, MD, Stephen L. Kopecky, MD, Guy S. Reeder, MD

The Red Scalp Sign Mayo Clinic Proceedings

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Peripartum Cardiomyopathy Presenting as an Acute Myocardial Infarction

Antidepressants and Brain Neurochemistry

Acquired Binocular Horizontal Diplopia

Expanding the Recognition and Assessment of Bleeding Events Associated With Antiplatelet Therapy in Primary Care Marc Cohen, MD Mayo Clinic Proceedings

NICHOLAS J. TALLEY, M.B., Ph.D., SIDNEY F. PHILLIPS, M.D.

L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis James J. DiNicolantonio, PharmD, Carl J. Lavie,

The Blindness of John Milton

Cyclophosphamide-Induced Hepatitis in Wegener's Granulomatosis

Adjunctive Therapies in the Treatment of Acute Coronary Syndromes

WILLIAM K. FREEMAN, M. D. , RAYMOND J. GIBBONS, M. D

Hepatocellular Carcinoma

Mark R. Wick, MD, Jon H. Ritter, MD, Dan Schuller, MD

Hepatitis C Genotypes: Current Trends and Future Implications

Strategies for Optimizing Glycemic Control and Cardiovascular Prognosis in Patients With Type 2 Diabetes Mellitus James H. O'Keefe, MD, Mohammad Abuannadi,

Effects of Niacin on Glucose Control in Patients With Dyslipidemia

Coronary Revascularization on Balance: Robert L. Frye Lecture

Mark A. Marinella, MD, Kenneth Greene, MD Mayo Clinic Proceedings

Protein-Losing Enteropathy After the Fontan Operation: Successful Treatment by Percutaneous Fenestration of the Atrial Septum Carole A. Warnes, M.D.,

Long-term outcome of dialysis patients in the United States with coronary revascularization procedures Charles A. Herzog, M.D., Jennie Z. Ma, Allan J.

Preoperative Smoking Cessation: The Role of the Primary Care Provider

Guy S. Reeder, M.D. Mayo Clinic Proceedings

David E. Winchester, MD, David C. Wymer, MD, Roger Y

Autonomic Tone and Benefits of Cardiac Rehabilitation Programs

Identification of Acute Transplacental Hemorrhage in a Low-Risk Patient as a Result of Daily Counting of Fetal Movements ROBERT H. HEISE, M.D., Jo T.

Guru Sonpavde, MD, Teresa G. Hayes, MD Mayo Clinic Proceedings

Managing Cancer Pain: Basic Principles and Invasive Treatments

Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical.

β-Blocker Use for the Stages of Heart Failure

Acute and Chronic Seizures in Patients Older Than 60 Years

Mayo Clinic Proceedings 2012: “A New Era in Journal Stewardship”

PATRICIA A. PELLIKKA, M. D. , THOMAS BEHRENBECK, M. D. , KENNETH C

NICHOLAS J. TALLEY, M.B., Ph.D., SIDNEY F. PHILLIPS, M.D.

Presentation transcript:

Acute Myocardial Infarction: Risk Stratification in the Thrombolytic Era Guy S. Reeder, M.D., Raymond J. Gibbons, M.D. Mayo Clinic Proceedings Volume 70, Issue 1, Pages 87-94 (February 1995) DOI: 10.4065/70.1.87 Copyright © 1995 Mayo Foundation for Medical Education and Research Terms and Conditions

Fig. 1 Severity of disease assessed by angiography. Number of diseased vessels in patients in prethrombolytic studies and in Thrombolysis in Myocardial Infarction (TIM1) trial. cath = catheterization; VD = vessel disease. (From Rogers and assoelates.46 By permission of the American College of Cardiology.) Mayo Clinic Proceedings 1995 70, 87-94DOI: (10.4065/70.1.87) Copyright © 1995 Mayo Foundation for Medical Education and Research Terms and Conditions

Fig. 2 Patient selection effects in risk stratification studies in thrombolytic era. * = high-risk patients excluded before noninvasive testing—selection effects that render noninvasive testing less useful for predicting death or myocardial infarction (MI) in current era of thrombolytic therapy. PTCA = percutaneous transluminal coronary angioplasty. Mayo Clinic Proceedings 1995 70, 87-94DOI: (10.4065/70.1.87) Copyright © 1995 Mayo Foundation for Medical Education and Research Terms and Conditions

Fig. 3 Mortality at 2 weeks relative to number of “not low-risk” factors (see Table 4). Mayo Clinic Proceedings 1995 70, 87-94DOI: (10.4065/70.1.87) Copyright © 1995 Mayo Foundation for Medical Education and Research Terms and Conditions